Mouse MAPC-mediated immunomodulation: Cell-line dependent variation

Experimental Hematology

Volumn 38, Issue 1, 2010, Pages 1-2

  Luyckx, Ariane ^a   De Somer, Lien ^a   Rutgeerts, Omer ^a   Waer, Mark ^a   Verfaillie, Catherine M ^a   Van Gool, Stefaan ^a   Billiau, An D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4;

ADULT STEM CELL; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; CELL FUNCTION; CELL HOMING; CELL TYPE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; IMMUNOSTIMULATION; LETTER; MEMORY T LYMPHOCYTE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; IMMUNOMODULATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; STEM CELLS;

EID: 71249141145     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.10.009     Document Type: Letter

References (10)

1. Nauta A.J., and Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007) 3499-3506
2. Sudres M., Norol F., Trenado A., et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 176 (2006) 7761-7767
3. Le Blanc K., Frassoni F., Ball L., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371 (2008) 1579-1586
4. Kovacsovics-Bankowski M., Streeter P.R., Mauch K.A., et al. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cell Immunol 255 (2009) 55-60
5. Highfill S.L., Kelly R.M., O'Shaughnessy M.J., et al. Multipotent adult progenitor cells (MAPC) can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood 114 (2009) 693-701
6. Ulloa-Montoya F., Kidder B.L., Pauwelyn K.A., et al. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 8 (2007) R163
7. Serafini M., Dylla S.J., Oki M., et al. Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. J Exp Med 204 (2007) 129-139
8. Koch C.A., Geraldes P., and Platt J.L. Immunosuppression by embryonic stem cells. Stem Cells 26 (2008) 89-98
9. Le Blanc K., Rasmusson I., Götherström C., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 (2003) 11-20
10. Nauta A.J., Westerhuis G., Kruisselbrink A.B., et al. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108 (2006) 2114-2120